CymaBay Therapeutics, Inc.·4

Jan 27, 4:30 PM ET

KIM DENNIS D 4

4 · CymaBay Therapeutics, Inc. · Filed Jan 27, 2023

Insider Transaction Report

Form 4
Period: 2023-01-25
KIM DENNIS D
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-01-25+180,000180,000 total
    Exercise: $7.80Exp: 2033-01-24Common Stock (180,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/48 of the underlying shares monthly from January 1, 2023.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES